Max Robotics — Global Service Robot Directory + US Certification

About

Amelia Evoli is a leading authority in the clinical management of myasthenia gravis (MG), with a career dedicated to understanding the intricate relationship between the thymus and neuromuscular autoimmunity. Her research has fundamentally shaped how severe and thymomatous MG is treated, particularly through the lens of surgical intervention. In her landmark work, "Thymectomy in severe generalized myasthenia gravis," she tackles the high-stakes question of whether the benefits of thymectomy outweigh the significant risks of postoperative crisis in the most fragile patients (MGFA classes IV–V). This study, alongside her pioneering evaluation of robotic thymectomy for patients with thymoma, has provided crucial evidence that aggressive surgical management can be safe and effective even in advanced disease. With her most-cited work already garnering attention, Evoli’s contributions are not just academic; they directly inform the risk-benefit calculus for neurologists and surgeons worldwide, offering hope for improved long-term neurological outcomes in a population once considered too high-risk for surgery.